CCEL
Cryo-Cell International Inc
$
4.200
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
4.320
Open
4.2601
VWAP
4.25
Vol
4.07K
Mkt Cap
33.83M
Low
4.200
Amount
17.30K
EV/EBITDA(TTM)
7.33
Total Shares
8.10M
EV
39.00M
EV/OCF(TTM)
6.14
P/S(TTM)
1.07
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
7.50M
-5.06%
-0.090
-292.31%
7.60M
-4.63%
-0.090
-267.6%
7.70M
-4.04%
-0.090
-64.64%
Estimates Revision
The market is revising Upward the revenue expectations for Cryo-Cell International, Inc. (CCEL) for FY2025, with the revenue forecasts being adjusted by 0.15% over the past three months. During the same period, the stock price has changed by -15.15%.
Revenue Estimates for FY2025
Revise Upward
+0.15%
In Past 3 Month
EPS Estimates for FY2025
No Change
0.00%
In Past 3 Month
Stock Price
Go Down
-15.15%
In Past 3 Month
Valuation Metrics
The current forward P/E ratio for Cryo-Cell International Inc (CCEL.A) is -10.77, compared to its 5-year average forward P/E of 19.90. For a more detailed relative valuation and DCF analysis to assess Cryo-Cell International Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
19.90
Current PE
-10.77
Overvalued PE
120.02
Undervalued PE
-80.21
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
12.88
Current EV/EBITDA
14.90
Overvalued EV/EBITDA
22.20
Undervalued EV/EBITDA
3.56
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Overvalued
5Y Average PS
1.34
Current PS
4.20
Overvalued PS
2.20
Undervalued PS
0.47
Financials
Annual
Quarterly
FY2025Q3
YoY :
-2.99%
7.83M
Total Revenue
FY2025Q3
YoY :
+35.50%
1.90M
Operating Profit
FY2025Q3
YoY :
-28.74%
749.41K
Net Income after Tax
FY2025Q3
YoY :
-30.77%
0.09
EPS - Diluted
FY2025Q3
YoY :
+10.94%
2.50M
Free Cash Flow
FY2025Q3
YoY :
+4.75%
74.61
Gross Profit Margin - %
FY2025Q3
YoY :
+100.82%
19.48
FCF Margin - %
FY2025Q3
YoY :
-26.53%
9.58
Net Margin - %
FY2025Q3
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
8
266.5K
USD
Months
3-6
7
285.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
8
266.5K
USD
Months
3-6
7
285.6K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CCEL News & Events
Events Timeline
2025-08-14 (ET)
2025-08-14
09:03:13
Cryo-Cell will not declare dividend in Q3
2025-07-15 (ET)
2025-07-15
17:06:40
Cryo-Cell reports Q2 EPS 4c vs. 8c last year.
2025-04-15 (ET)
2025-04-15
09:18:14
Cryo-Cell reports Q1 EPS 3c vs. 7c last year
Sign Up For More Events
Sign Up For More Events
News
9.5
10-16NASDAQ.COMCryo-Cell International Inc Reports Decrease in Q3 Profit
5.0
09-12NASDAQ.COMInsider Buying Update for Friday, September 12: CCEL, AROW
8.0
05-08NewsfilterCord Blood Banking Leader Cryo-Cell Announces Cash Dividend
Sign Up For More News
People Also Watch
TYGO
Tigo Energy Inc
2.220
USD
-2.63%
BAYA
Bayview Acquisition Corp
11.250
USD
0.00%
GANX
Gain Therapeutics Inc
1.960
USD
+3.16%
FKWL
Franklin Wireless Corp
5.040
USD
+0.20%
SACH
Sachem Capital Corp
1.060
USD
0.00%
SELX
Semilux International Ltd
0.566
USD
-29.97%
HOWL
Werewolf Therapeutics Inc
1.150
USD
-4.17%
MIND
Mind Technology Inc
13.200
USD
+5.94%
SELF
Global Self Storage Inc
4.980
USD
+1.63%
FAQ
What is Cryo-Cell International Inc (CCEL) stock price today?
The current price of CCEL is 4.2 USD — it has decreased -2.33 % in the last trading day.
What is Cryo-Cell International Inc (CCEL)'s business?
What is the price predicton of CCEL Stock?
What is Cryo-Cell International Inc (CCEL)'s revenue for the last quarter?
What is Cryo-Cell International Inc (CCEL)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Cryo-Cell International Inc (CCEL)'s fundamentals?
How many employees does Cryo-Cell International Inc (CCEL). have?